Karl Grozinger

1.7k total citations · 1 hit paper
34 papers, 1.4k citations indexed

About

Karl Grozinger is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Karl Grozinger has authored 34 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Organic Chemistry, 11 papers in Molecular Biology and 9 papers in Infectious Diseases. Recurrent topics in Karl Grozinger's work include HIV/AIDS drug development and treatment (9 papers), Chemical Synthesis and Analysis (6 papers) and HIV Research and Treatment (5 papers). Karl Grozinger is often cited by papers focused on HIV/AIDS drug development and treatment (9 papers), Chemical Synthesis and Analysis (6 papers) and HIV Research and Treatment (5 papers). Karl Grozinger collaborates with scholars based in United States, Canada and Germany. Karl Grozinger's co-authors include Karl D. Hargrave, Julian Adams, Richard A. Koup, Mark E. Labadia, Robert J. Eckner, John L. Sullivan, Joseph C. Wu, Susan E. Hattox, Alan S. Rosenthal and Ronald B. Faanes and has published in prestigious journals such as Science, Journal of the American Chemical Society and Journal of Medicinal Chemistry.

In The Last Decade

Karl Grozinger

32 papers receiving 1.4k citations

Hit Papers

Inhibition of HIV-1 Replication by a Nonnucleoside Revers... 1990 2026 2002 2014 1990 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karl Grozinger United States 14 770 664 619 439 156 34 1.4k
Norman E. Wideburg United States 13 888 1.2× 603 0.9× 710 1.1× 613 1.4× 149 1.0× 29 1.5k
Kouichi Sekiya Japan 17 836 1.1× 741 1.1× 591 1.0× 372 0.8× 219 1.4× 25 1.5k
John Wai United States 17 936 1.2× 828 1.2× 768 1.2× 649 1.5× 184 1.2× 30 1.7k
Masaru Ubasawa Japan 19 944 1.2× 566 0.9× 667 1.1× 512 1.2× 245 1.6× 34 1.5k
Cheng-Kon Shih United States 13 681 0.9× 348 0.5× 595 1.0× 337 0.8× 162 1.0× 16 1.1k
Hirohiko Sugimoto Japan 15 547 0.7× 453 0.7× 456 0.7× 403 0.9× 100 0.6× 36 1.1k
James P. Guare United States 14 432 0.6× 546 0.8× 369 0.6× 425 1.0× 81 0.5× 32 1.1k
Karl D. Hargrave United States 17 952 1.2× 1.1k 1.7× 765 1.2× 576 1.3× 292 1.9× 30 2.2k
Beverly C. Cordova United States 20 557 0.7× 889 1.3× 499 0.8× 526 1.2× 146 0.9× 34 1.8k
Sudthida Vasavanonda United States 16 1.5k 2.0× 481 0.7× 1.3k 2.0× 488 1.1× 217 1.4× 27 2.1k

Countries citing papers authored by Karl Grozinger

Since Specialization
Citations

This map shows the geographic impact of Karl Grozinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Grozinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Grozinger more than expected).

Fields of papers citing papers by Karl Grozinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl Grozinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Grozinger. The network helps show where Karl Grozinger may publish in the future.

Co-authorship network of co-authors of Karl Grozinger

This figure shows the co-authorship network connecting the top 25 collaborators of Karl Grozinger. A scholar is included among the top collaborators of Karl Grozinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Grozinger. Karl Grozinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grozinger, Karl, et al.. (2017). Efficient synthesis of α-fluoromethylhistidine di-hydrochloride and demonstration of its efficacy as a glutathione S-transferase inhibitor. Bioorganic & Medicinal Chemistry Letters. 27(6). 1335–1340. 3 indexed citations
2.
Davis, David, et al.. (2009). Challenges and Potential for RNA Nanoparticles (RNPs). Journal of Biomedical Nanotechnology. 5(1). 36–44. 5 indexed citations
3.
Latli, Bachir, et al.. (2008). Synthesis of [14C] ‐ and [13C6]‐labeled tipranavir and its potential hydroxyl metabolite and the glucuronide conjugate. Journal of Labelled Compounds and Radiopharmaceuticals. 51(8). 314–320. 5 indexed citations
4.
Beaulieu, Pierre L., James Gillard, Murray D. Bailey, et al.. (2005). Synthesis of (1R,2S)-1-Amino-2-vinylcyclopropanecarboxylic Acid Vinyl-ACCA) Derivatives:  Key Intermediates for the Preparation of Inhibitors of the Hepatitis C Virus NS3 Protease. The Journal of Organic Chemistry. 70(15). 5869–5879. 65 indexed citations
5.
Busacca, Carl A., Scot Campbell, Anjan K. Saha, et al.. (2005). Structure elucidation and total synthesis of a unique group of trace impurities in Tipranavir® drug product. Magnetic Resonance in Chemistry. 43(12). 1032–1039. 5 indexed citations
6.
Wang, Xiao‐jun, Jonathan Tan, & Karl Grozinger. (2000). Cross-coupling of 1-aryl-5-bromopyrazoles: regioselective synthesis of 3,5-disubstituted 1-arylpyrazoles. Tetrahedron Letters. 41(24). 4713–4716. 56 indexed citations
7.
Wang, Xiao‐jun, et al.. (2000). Practical synthesis of 1,3-diaryl-5-alkylpyrazoles by a highly regioselective N-arylation of 3,5-disubstituted pyrazoles with 4-fluoronitrobenzene. Tetrahedron Letters. 41(28). 5321–5324. 24 indexed citations
10.
Skiles, Jerry W., Clara K. Miao, Ronald Sorcek, et al.. (1992). Inhibition of human leukocyte elastase (HLE) by N-substituted peptidyl trifluoromethyl ketones. Journal of Medicinal Chemistry. 35(4). 641–662. 38 indexed citations
11.
Hargrave, Karl D., et al.. (1991). Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 1. Tricyclic pyridobenzo- and dipyridodiazepinones. Journal of Medicinal Chemistry. 34(7). 2231–2241. 183 indexed citations
12.
Koup, Richard A., V J Merluzzi, Karl D. Hargrave, et al.. (1991). Inhibition of Human Immunodeficiency Virus Type I (HIV-I) Replication by the Dipyridodiazepinone BI-RG-587. The Journal of Infectious Diseases. 163(5). 966–970. 101 indexed citations
13.
15.
Grozinger, Karl, et al.. (1976). Amidomethylierung von Indolen. Justus Liebig s Annalen der Chemie. 1976(2). 241–249. 6 indexed citations
16.
Just, George, Alain Martel, Karl Grozinger, & Mohabir Ramjeesingh. (1975). C -Nucleosides and Related Compounds. IV. The Synthesis and Chemistry of D,L-2,5-Anhydroallose Derivatives. Canadian Journal of Chemistry. 53(1). 131–137. 24 indexed citations
17.
Just, George & Karl Grozinger. (1975). A Total Synthesis of Dimethyl 2,3-O-Isopropylidene-l-O-oxalyl-β-DL-ribo-hexofuran-5-ulosuronate. Canadian Journal of Chemistry. 53(18). 2701–2706. 3 indexed citations
18.
Just, George & Karl Grozinger. (1974). A correction to “A novel periodate cleavage”. Tetrahedron Letters. 15(47). 4165–4168. 4 indexed citations
19.
Götz, M. & Karl Grozinger. (1971). 3-hydroxysydnone imines. Tetrahedron. 27(19). 4449–4456. 10 indexed citations
20.
Grozinger, Karl, et al.. (1971). A facile route for the preparation of 4-aminomethylacridine and its derivatives. Tetrahedron Letters. 12(28). 2591–2594. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026